These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8200422)

  • 1. Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101.
    Noble F; Coric P; Turcaud S; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1994 Mar; 253(3):283-7. PubMed ID: 8200422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101.
    Noble F; Coric P; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1992 Nov; 223(1):91-6. PubMed ID: 1478261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
    Maldonado R; Valverde O; Ducos B; Blommaert AG; Fournie-Zaluski MC; Roques BP
    Br J Pharmacol; 1995 Mar; 114(5):1031-9. PubMed ID: 7780637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.
    Ruiz F; Fournié-Zaluski MC; Roques BP; Maldonado R
    Br J Pharmacol; 1996 Sep; 119(1):174-82. PubMed ID: 8872371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome.
    Maldonado R; Daugé V; Callebert J; Villette JM; Fournié-Zaluski MC; Feger J; Roques BP
    Eur J Pharmacol; 1989 Jun; 165(2-3):199-207. PubMed ID: 2776828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
    Maldonado R; Feger J; Fournié-Zaluski MC; Roques BP
    Brain Res; 1990 Jun; 520(1-2):247-54. PubMed ID: 2169953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.
    Maldonado R; Fournié-Zaluski MC; Roques BP
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):466-72. PubMed ID: 1620246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice.
    Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1993 Jan; 230(2):139-49. PubMed ID: 8422896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
    Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
    Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding.
    Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP
    Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
    Noble F; Turcaud S; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1992 Nov; 223(1):83-9. PubMed ID: 1478260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physical dependence liability of butorphanol: a comparative study with morphine.
    Horan P; Ho IK
    Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
    Le Guen S; Noble F; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
    Eur J Pharmacol; 2002 Apr; 441(3):141-50. PubMed ID: 12063085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation.
    Noble F; Fournié-Zaluski MC; Roques BP
    Neuropharmacology; 1994 Jan; 33(1):135-40. PubMed ID: 7910383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opioid peptide analogue biphalin induces less physical dependence than morphine.
    Yamazaki M; Suzuki T; Narita M; Lipkowski AW
    Life Sci; 2001 Jul; 69(9):1023-8. PubMed ID: 11508644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
    Boudinot E; Morin-Surun M; Foutz AS; Fournié-Zaluski M; Roques BP; Denavit-Saubié M
    Pain; 2001 Feb; 90(1-2):7-13. PubMed ID: 11166965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids.
    Valverde O; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1996 Sep; 312(1):15-25. PubMed ID: 8891574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
    Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.